The Effect of Semi-recumbent Position on Hypoxemia After Lung Segment/Lobe Surgery
Launched by SHANGHAI PULMONARY HOSPITAL, SHANGHAI, CHINA · Jul 1, 2025
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Thoracoscopic surgery is the most common surgical approach in thoracic surgery, which reduces surgical trauma and postoperative pain compared with open thoracotomy, but postoperative complications should not be overlooked, with hypoxemia being particularly prominent. Postoperative hypoxemia is highly prevalent among patients recovering from non-cardiac surgery, accounting for over one-third of all cases. Hypoxemia impairs wound healing and leads to other severe complications such as cerebral dysfunction, arrhythmia, and myocardial ischemia, all of which adversely affect postoperative recove...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-85 years old; Undergo thoracoscopic segment/lobectomy; American Society of Anesthesiologists (ASA) grade 1\~3
- Exclusion Criteria:
- • Patients with mental or cognitive dysfunction who cannot communicate normally; Patients with tracheal catheters retained in ICU; Patients with cervical spondylosis, ankylosing spondylitis and other patients who cannot lift their upper body; Patients who have participated in other clinical trials; Patients who refuse to sign informed consent; Patients who have had chest surgery in the past.
About Shanghai Pulmonary Hospital, Shanghai, China
Shanghai Pulmonary Hospital, located in Shanghai, China, is a leading institution dedicated to the research and treatment of respiratory diseases. Renowned for its comprehensive clinical care and advanced research initiatives, the hospital specializes in pulmonary medicine and is committed to improving patient outcomes through innovative clinical trials. With a multidisciplinary team of experts and state-of-the-art facilities, Shanghai Pulmonary Hospital aims to contribute significantly to the global understanding and management of respiratory conditions, fostering advancements in therapeutic strategies and healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Yang Hao, postdoctor
Study Director
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported